MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2020-01-20 for SPROTTE 2.G 121251-27A 001151-683 manufactured by Pajunk Gmbh Medizintechnologie.
| Report Number | 9611612-2020-00002 |
| MDR Report Key | 9605110 |
| Report Source | DISTRIBUTOR |
| Date Received | 2020-01-20 |
| Date of Report | 2020-02-18 |
| Date of Event | 2020-01-07 |
| Date Mfgr Received | 2020-01-10 |
| Date Added to Maude | 2020-01-20 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 3 |
| Reporter Occupation | RISK MANAGER |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 3 |
| Event Location | 3 |
| Manufacturer Contact | MR CHRISTIAN QUASS |
| Manufacturer Street | KARL-HALL-STR. 1 TUTTLINGER STR. 7 |
| Manufacturer City | GEISINGEN, 78187 |
| Manufacturer Country | GM |
| Manufacturer Postal | 78187 |
| Manufacturer G1 | PAJUNK GMBH MEDIZINTECHNOLOGIE |
| Manufacturer Street | KARL-HALL-STR. 1 TUTTLINGER STR. 7 |
| Manufacturer City | GEISINGEN, 78187 |
| Manufacturer Country | GM |
| Manufacturer Postal Code | 78187 |
| Single Use | 3 |
| Previous Use Code | 3 |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | SPROTTE 2.G |
| Generic Name | SPINAL NEEDLE, SINGLE USE |
| Product Code | BSP |
| Date Received | 2020-01-20 |
| Returned To Mfg | 2020-01-16 |
| Model Number | 121251-27A |
| Catalog Number | 001151-683 |
| Lot Number | UNKNOWN |
| Operator | HEALTH PROFESSIONAL |
| Device Availability | R |
| Device Age | DA |
| Device Eval'ed by Mfgr | Y |
| Device Sequence No | 1 |
| Device Event Key | 0 |
| Manufacturer | PAJUNK GMBH MEDIZINTECHNOLOGIE |
| Manufacturer Address | KARL-HALL-STR. 1 TUTTLINGER STR. 7 GEISINGEN, 78187 GM 78187 |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 1. Other; 2. Required No Informationntervention | 2020-01-20 |